Listed

Arbutus Biopharma Corp: Form 10-Q for the period ended Sep 30, 2014

Filed with the SEC on Nov 7, 2014 and accepted by EDGAR at Nov 6, 2014, 20:45 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-07-01 to 2014-09-30$4.4mus-gaap:Revenues
Revenue9 months2014-01-01 to 2014-09-30$10.6mus-gaap:Revenues
Research and development3 months2014-07-01 to 2014-09-30$9.3mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2014-01-01 to 2014-09-30$26.8mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2014-07-01 to 2014-09-30−$6.8mus-gaap:OperatingIncomeLoss
Operating income9 months2014-01-01 to 2014-09-30−$22.2mus-gaap:OperatingIncomeLoss
Net income3 months2014-07-01 to 2014-09-30−$8.6mus-gaap:NetIncomeLoss
Net income9 months2014-01-01 to 2014-09-30−$32.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-07-01 to 2014-09-30−$0.39us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2014-01-01 to 2014-09-30−$1.53us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2014-07-01 to 2014-09-30−$6.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow9 months2014-01-01 to 2014-09-30−$5.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2014-07-01 to 2014-09-30$152.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Capital expenditure9 months2014-01-01 to 2014-09-30$733.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-09-30$78.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-09-30$111.7mus-gaap:AssetsCurrent
Total assetsAt period end2014-09-30$125.1mus-gaap:Assets
Current liabilitiesAt period end2014-09-30$19.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-09-30$29.6mus-gaap:Liabilities
Shareholders' equityAt period end2014-09-30$95.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001171843-14-005345. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.